Other genetic events characteristic for ABC DLBCL involve components of the B cell receptor (CD79A and CD79B) and regulators of the NF-κB pathway (MYD88) [12, 13]. The gene discussed is NFKB1; the disease is diffuse large B-cell lymphoma.